Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Beneleaves has demonstrated a strong performance in the Ohio market, particularly in the Capsules category where it has consistently maintained the top position from December 2025 through March 2026. This sustained leadership indicates a robust demand and effective market strategy in this segment. Despite a slight dip in sales after January, the brand's ability to hold onto the number one spot suggests a loyal consumer base and possibly a lack of strong competition in this category. In contrast, the Topical category presents a different picture, where Beneleaves has remained in the 7th and 8th positions over the same period. This stability in ranking, albeit not at the top, might reflect a steady but not dominant presence, possibly due to stronger competitors or different consumer preferences in this category.
While Beneleaves' performance in Ohio is noteworthy, the absence of rankings in other states or provinces within the top 30 brands could be seen as a limitation in their geographical reach or market penetration outside Ohio. This lack of presence in other regions might suggest either a strategic focus on their home market or challenges in expanding their brand recognition and distribution network. The brand's strategy might benefit from exploring new markets or enhancing their offerings in categories where they already have a foothold, like Capsules, to replicate their success in Ohio elsewhere. Understanding the dynamics of these categories and consumer preferences in different states could provide valuable insights for potential expansion.
Competitive Landscape
In the Ohio capsules market, Beneleaves has consistently maintained its position as the top-ranked brand from December 2025 through March 2026. This stability in rank suggests a strong brand presence and customer loyalty in the region. Despite a slight decrease in sales from February to March 2026, Beneleaves continues to outperform its closest competitors. For instance, UB GOOD, which holds the second rank, shows a steady decline in sales over the same period, indicating potential challenges in maintaining its market share. Meanwhile, Main Street Health has improved its rank from fourth to third, with a notable increase in sales from December 2025 to February 2026, although it remains significantly behind Beneleaves in terms of total sales volume. These dynamics highlight Beneleaves' robust market leadership and suggest opportunities for further growth if it can continue to capitalize on its competitive advantages.

Notable Products
In March 2026, the top-performing product from Beneleaves was the RSO Capsules 22-Pack (660mg), maintaining its consistent first-place rank since December 2025, with sales reaching 3816 units. The Sativa Helios Capsules 11-Pack (440mg) also held steady in second place, showing a slight increase in sales from February. The CBD/THC/CBG/CBC/CBN Entourage Effect Capsules 22-Pack remained in third place, although sales dipped slightly compared to the previous month. The Hypnos Indica Capsules 11-Pack re-emerged in the rankings in fourth place after being unranked for two months, indicating a resurgence in popularity. Lastly, the Hybrid RSO Capsules 11-Pack continued to hold fifth place, showing steady demand in the market.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







